Systematic Profiling of Alternative Splicing Events in Ovarian Cancer

被引:7
作者
Liu, Jia [1 ]
Lv, Dekang [2 ]
Wang, Xiaobin [1 ]
Wang, Ruicong [3 ]
Li, Xiaodong [2 ]
机构
[1] China Med Univ, Dept Gynecol, Liaoning Canc Hosp & Inst, Canc Hosp, Shenyang, Peoples R China
[2] Dalian Med Univ, Canc Ctr, Inst Canc Stem Cell, Dalian, Peoples R China
[3] Dalian Med Univ, Dept Gynecol & Obster, Affiliated Hosp 1, Dalian, Peoples R China
关键词
ovarian cancer; alternative splicing; integrated prognostic model; LASSO; splicing factor; IGF2BP3; IMP3; CLN3; GENE; PROLIFERATION; CARCINOMA; PROGNOSIS; SIGNATURE; TARGET;
D O I
10.3389/fonc.2021.622805
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Alternative splicing (AS) is significantly related to the development of tumor and the clinical outcome of patients. In this study, our aim was to systematically analyze the survival-related AS signal in ovarian serous cystadenocarcinoma (OV) and estimate its prognostic validity in 48,049 AS events out of 21,854 genes. We studied 1,429 AS events out of 1,125 genes, which were significantly related to the overall survival (OS) in patients with OV. We established alternative splicing features on the basis of seven AS events and constructed a new comprehensive prognostic model. Kaplan-Meier curve analysis showed that seven AS characteristics and comprehensive prognostic models could strongly stratify patients with ovarian cancer and make them distinctive prognosis. ROC analysis from 0.781 to 0.888 showed that these models were highly efficient in distinguishing patient survival. We also verified the prognostic characteristics of these models in a testing cohort. In addition, uni-variate and multivariate Cox analysis showed that these models were superior independent risk factors for OS in patients with OV. Interestingly, AS events and splicing factor (SFs) networks revealed an important link between these prognostic alternative splicing genes and splicing factors. We also found that the comprehensive prognosis model signature had higher prediction ability than the mRNA signature. In summary, our study provided a possible prognostic prediction model for patients with OV and revealed the splicing network between AS and SFs, which could be used as a potential predictor and therapeutic target for patients with OV.
引用
收藏
页数:11
相关论文
共 36 条
[1]   Treatment of renal cell carcinoma: Current status and future directions [J].
Barata, Pedro C. ;
Rini, Brian I. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (06) :507-524
[2]   C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors [J].
Barroilhet, L. ;
Yang, J. ;
Hasselblatt, K. ;
Paranal, R. M. ;
Ng, S-K ;
Rauh-Hain, J. A. ;
Welch, W. R. ;
Bradner, J. E. ;
Berkowitz, R. S. ;
Ng, S-W .
ONCOGENE, 2013, 32 (33) :3896-3903
[3]   Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations [J].
Caminsky, Natasha G. ;
Mucaki, Eliseos J. ;
Perri, Ami M. ;
Lu, Ruipeng ;
Knoll, Joan H. M. ;
Rogan, Peter K. .
HUMAN MUTATION, 2016, 37 (07) :640-652
[4]   Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA [J].
Earp, Madalene A. ;
Kelemen, Linda E. ;
Magliocco, Anthony M. ;
Swenerton, Kenneth D. ;
Chenevix-Trench, Georgia ;
Lu, Yi ;
Hein, Alexander ;
Ekici, Arif B. ;
Beckmann, Matthias W. ;
Fasching, Peter A. ;
Lambrechts, Diether ;
Despierre, Evelyn ;
Vergote, Ignace ;
Lambrechts, Sandrina ;
Doherty, Jennifer A. ;
Rossing, Mary Anne ;
Chang-Claude, Jenny ;
Rudolph, Anja ;
Friel, Grace ;
Moysich, Kirsten B. ;
Odunsi, Kunle ;
Sucheston-Campbell, Lara ;
Lurie, Galina ;
Goodman, Marc T. ;
Carney, Michael E. ;
Thompson, Pamela J. ;
Runnebaum, Ingo B. ;
Duerst, Matthias ;
Hillemanns, Peter ;
Doerk, Thilo ;
Antonenkova, Natalia ;
Bogdanova, Natalia ;
Leminen, Arto ;
Nevanlinna, Heli ;
Pelttari, Liisa M. ;
Butzow, Ralf ;
Bunker, Clareann H. ;
Modugno, Francesmary ;
Edwards, Robert P. ;
Ness, Roberta B. ;
du Bois, Andreas ;
Heitz, Florian ;
Schwaab, Ira ;
Harter, Philipp ;
Karlan, Beth Y. ;
Walsh, Christine ;
Lester, Jenny ;
Jensen, Allan ;
Kjaer, Susanne K. ;
Hogdall, Claus K. .
HUMAN GENETICS, 2014, 133 (05) :481-497
[5]   High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer [J].
Enroth, Stefan ;
Berggrund, Malin ;
Lycke, Maria ;
Broberg, John ;
Lundberg, Martin ;
Assarsson, Erika ;
Olovsson, Matts ;
Stalberg, Karin ;
Sundfeldt, Karin ;
Gyllensten, Ulf .
COMMUNICATIONS BIOLOGY, 2019, 2 (1)
[6]   Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer [J].
Hsu, K-F ;
Shen, M-R ;
Huang, Y-F ;
Cheng, Y-M ;
Lin, S-H ;
Chow, N-H ;
Cheng, S-W ;
Chou, C-Y ;
Ho, C-L .
BRITISH JOURNAL OF CANCER, 2015, 113 (03) :414-424
[7]   Mutually exclusive alternative splicing of pre-mRNAs [J].
Jin, Yongfeng ;
Dong, Haiyang ;
Shi, Yang ;
Bian, Lina .
WILEY INTERDISCIPLINARY REVIEWS-RNA, 2018, 9 (03)
[8]   A circRNA signature predicts postoperative recurrence in stage II/III colon cancer [J].
Ju, Huai-Qiang ;
Zhao, Qi ;
Wang, Feng ;
Lan, Ping ;
Wang, Zixian ;
Zuo, Zhi-Xiang ;
Wu, Qi-Nian ;
Fan, Xin-Juan ;
Mo, Hai-Yu ;
Chen, Li ;
Li, Ting ;
Ren, Chao ;
Wan, Xiang-Bo ;
Chen, Gong ;
Li, Yu-Hong ;
Jia, Wei-Hua ;
Xu, Rui-Hua .
EMBO MOLECULAR MEDICINE, 2019, 11 (10)
[9]   IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype [J].
Koebel, Martin ;
Xu, Haodong ;
Bourne, Patricia A. ;
Spaulding, Betsy O. ;
Shih, Ie-Ming ;
Mao, Tsui-Lien ;
Soslow, Robert A. ;
Ewanowich, Carol A. ;
Kalloger, Steve E. ;
Mehl, Erika ;
Lee, Cheng-Han ;
Huntsman, David ;
Gilks, C. Blake .
MODERN PATHOLOGY, 2009, 22 (03) :469-475
[10]   MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis [J].
Koh, Cheryl M. ;
Bezzi, Marco ;
Low, Diana H. P. ;
Ang, Wei Xia ;
Teo, Shun Xie ;
Gay, Florence P. H. ;
Al-Haddawi, Muthafar ;
Tan, Soo Yong ;
Osato, Motomi ;
Sabo, Arianna ;
Amati, Bruno ;
Wee, Keng Boon ;
Guccione, Ernesto .
NATURE, 2015, 523 (7558) :96-+